<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35805131</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2049</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11132049</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and highly fatal neurodegenerative disease. Although the pathogenesis of ALS remains unclear, increasing evidence suggests that a key contributing factor is mitochondrial dysfunction. Mitochondria are organelles in eukaryotic cells responsible for bioenergy production, cellular metabolism, signal transduction, calcium homeostasis, and immune responses and the stability of their function plays a crucial role in neurons. A single disorder or defect in mitochondrial function can lead to pathological changes in cells, such as an impaired calcium buffer period, excessive generation of free radicals, increased mitochondrial membrane permeability, and oxidative stress (OS). Recent research has also shown that these mitochondrial dysfunctions are also associated with pathological changes in ALS and are believed to be commonly involved in the pathogenesis of the disease. This article reviews the latest research on mitochondrial dysfunction and its impact on the progression of ALS, with specific attention to the potential of novel therapeutic strategies targeting mitochondrial dysfunction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jiantao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7228-5274</Identifier><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3527-2191</Identifier><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Zijun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4740-9228</Identifier><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinmeng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6041-2723</Identifier><AffiliationInfo><Affiliation>Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhenhan</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7679-6821</Identifier><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Fandi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lingyun</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3571-3209</Identifier><AffiliationInfo><Affiliation>Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huancai</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3093-4915</Identifier><AffiliationInfo><Affiliation>Department of Joint Surgery, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shuanhu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4745-5347</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35805131</ArticleId><ArticleId IdType="pmc">PMC9265651</ArticleId><ArticleId IdType="doi">10.3390/cells11132049</ArticleId><ArticleId IdType="pii">cells11132049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mehta P., Kaye W., Bryan L., Larson T., Copeland T., Wu J., Muravov O., Horton K. Prevalence of Amyotrophic Lateral Sclerosis&#x2014;United States, 2012&#x2013;2013. Morb. Mortal. Wkly. Rep. Surveill. Summ. 2016;65:1&#x2013;12. doi: 10.15585/mmwr.ss6508a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.ss6508a1</ArticleId><ArticleId IdType="pubmed">27490513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali&#xf3; M.L., Henriques E., Siena A., Bertoncini C.R.A., Gil-Mohapel J., Rosenstock T.R. Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment. Front. Neurosci. 2016;15:679. doi: 10.3389/fnins.2020.00679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00679</ArticleId><ArticleId IdType="pmc">PMC7373761</ArticleId><ArticleId IdType="pubmed">32760239</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini M., Oliveira A.B., Nascimento O.J., Reis C.H.M., Leite M.A.A., De Souza J.A., Pupe C., De Souza O.G., Bastos V.H., De Freitas M.R., et al. Amyotrophic Lateral Sclerosis: New Perpectives and Update. Neurol. Int. 2015;7:39&#x2013;47. doi: 10.4081/ni.2015.5885.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2015.5885</ArticleId><ArticleId IdType="pmc">PMC4591493</ArticleId><ArticleId IdType="pubmed">26487927</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;12:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V., The ALS/Riluzole Study Group A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H., Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study) Amyotroph. Lateral Scler. 2006;7:247&#x2013;251. doi: 10.1080/17482960600881870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600881870</ArticleId><ArticleId IdType="pubmed">17127563</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Orrell R.W. Pathogenesis of amyotrophic lateral sclerosis. Br. Med. Bull. 2016;119:87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H., Hardy J., Duff K.E. Selective vulnerability in neurodegenerative diseases. Nat. Neurosci. 2018;21:1350&#x2013;1358. doi: 10.1038/s41593-018-0221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0221-2</ArticleId><ArticleId IdType="pmc">PMC6360529</ArticleId><ArticleId IdType="pubmed">30250262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurcau A. Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress. Int. J. Mol. Sci. 2021;22:11847. doi: 10.3390/ijms222111847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111847</ArticleId><ArticleId IdType="pmc">PMC8584731</ArticleId><ArticleId IdType="pubmed">34769277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic M., Novakovic I., Dawod P.G.A., Dawod A.G.A., Drinic A., Motaleb F.I.A., Ducic S., Nikolic D. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:9832. doi: 10.3390/ijms22189832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189832</ArticleId><ArticleId IdType="pmc">PMC8469731</ArticleId><ArticleId IdType="pubmed">34575995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Zhang C., Guan Y., Chen Y., Lu Q., Jie L., Gao H., Du H., Zhang H., Liu Y., et al. Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: Altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9. J. Neurochem. 2017;145:51&#x2013;67. doi: 10.1111/jnc.14229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14229</ArticleId><ArticleId IdType="pubmed">28960306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralli M., Lambiase A., Artico M., de Vincentiis M., Greco A. Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives. Isr. Med. Assoc. J. 2019;7:438&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">31507117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Sagua R., Parra V., L&#xf3;pez-Crisosto C., D&#xed;az P., Quest A.F.G., Lavandero S. Calcium Transport and Signaling in Mitochondria. Compr. Physiol. 2017;7:623&#x2013;634. doi: 10.1002/cphy.c160013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c160013</ArticleId><ArticleId IdType="pubmed">28333383</ArticleId></ArticleIdList></Reference><Reference><Citation>Valero T. Mitochondrial biogenesis: Pharmacological approaches. Curr. Pharm. Des. 2014;20:5507&#x2013;5509. doi: 10.2174/138161282035140911142118.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161282035140911142118</ArticleId><ArticleId IdType="pubmed">24606795</ArticleId></ArticleIdList></Reference><Reference><Citation>Magner M., Kol&#xe1;&#x159;ov&#xe1; H., Honzik T., &#x160;vandov&#xe1; I., Zeman J. Clinical manifestation of mitochondrial diseases. Dev. Period Med. 2015;19:441&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">26982751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kausar S., Wang F., Cui H. The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases. Cells. 2018;7:274. doi: 10.3390/cells7120274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7120274</ArticleId><ArticleId IdType="pmc">PMC6316843</ArticleId><ArticleId IdType="pubmed">30563029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuto R., Duchen M.R., Pozzan T. Flirting in little space: The ER/mitochondria Ca2+ liaison. Sci. STKE. 2004;13:215. doi: 10.1126/stke.2152004re1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/stke.2152004re1</ArticleId><ArticleId IdType="pubmed">14722345</ArticleId></ArticleIdList></Reference><Reference><Citation>Patron M., Raffaello A., Granatiero V., Tosatto A., Merli G., De Stefani D., Wright L., Pallafacchina G., Terrin A., Mammucari C., et al. The mitochondrial calcium uniporter (MCU): Molecular identity and physiological roles. J. Biol. Chem. 2013;12:10750&#x2013;10758. doi: 10.1074/jbc.R112.420752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R112.420752</ArticleId><ArticleId IdType="pmc">PMC3624455</ArticleId><ArticleId IdType="pubmed">23400777</ArticleId></ArticleIdList></Reference><Reference><Citation>Santo-Domingo J., Demaurex N. Calcium uptake mechanisms of mitochondria. Biochim. Biophys. Acta. 2010;1797:907&#x2013;912. doi: 10.1016/j.bbabio.2010.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.01.005</ArticleId><ArticleId IdType="pubmed">20079335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallilankaraman K., Doonan P., C&#xe1;rdenas C., Chandramoorthy H.C., M&#xfc;ller M., Miller R., Hoffman N.E., Gandhirajan R.K., Molg&#xf3; J., Birnbaum M.J., et al. MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca2+ uptake that regulates cell survival. Cell. 2012;26:630&#x2013;644. doi: 10.1016/j.cell.2012.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.10.011</ArticleId><ArticleId IdType="pmc">PMC3486697</ArticleId><ArticleId IdType="pubmed">23101630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuto R., Pinton P., Carrington W., Fay F.S., Fogarty K.E., Lifshitz L.M., Tuft R.A., Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998;12:1763&#x2013;1766. doi: 10.1126/science.280.5370.1763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.280.5370.1763</ArticleId><ArticleId IdType="pubmed">9624056</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer J.N., Leuthner T.C., Luz A.L. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;391:42&#x2013;53. doi: 10.1016/j.tox.2017.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2017.07.019</ArticleId><ArticleId IdType="pmc">PMC5681418</ArticleId><ArticleId IdType="pubmed">28789970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pa&#xdf; T., Wiesner R.J., Pla-Mart&#xed;n D. Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus. Front. Mol. Biosci. 2021;30:676187. doi: 10.3389/fmolb.2021.676187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.676187</ArticleId><ArticleId IdType="pmc">PMC8290884</ArticleId><ArticleId IdType="pubmed">34295920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirabayashi Y., Kwon S.K., Paek H., Pernice W.M., Paul M.A., Lee J., Erfani P., Raczkowski A., Petrey D.S., Pon L.A., et al. ER-mitochondria tethering by PDZD8 regulates Ca2+ dynamics in mammalian neurons. Science. 2017;3:623&#x2013;630. doi: 10.1126/science.aan6009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6009</ArticleId><ArticleId IdType="pmc">PMC5818999</ArticleId><ArticleId IdType="pubmed">29097544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S.K., Sando R., 3rd, Lewis T.L., Hirabayashi Y., Maximov A., Polleux F. LKB1 Regulates Mitochondria-Dependent Presynaptic Calcium Clearance and Neurotransmitter Release Properties at Excitatory Synapses along Cortical Axons. PLoS Biol. 2016;14:e1002516. doi: 10.1371/journal.pbio.1002516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002516</ArticleId><ArticleId IdType="pmc">PMC4948842</ArticleId><ArticleId IdType="pubmed">27429220</ArticleId></ArticleIdList></Reference><Reference><Citation>Marland J.R., Hasel P., Bonnycastle K., Cousin M.A. Mitochondrial Calcium Uptake Modulates Synaptic Vesicle Endocytosis in Central Nerve Terminals. J. Biol. Chem. 2016;29:2080&#x2013;2086. doi: 10.1074/jbc.M115.686956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.686956</ArticleId><ArticleId IdType="pmc">PMC4732196</ArticleId><ArticleId IdType="pubmed">26644474</ArticleId></ArticleIdList></Reference><Reference><Citation>de Juan-Sanz J., Holt G.T., Schreiter E., de Juan F., Kim D.S., Ryan T.A. Axonal Endoplasmic Reticulum Ca2+ Content Controls Release Probability in CNS Nerve Terminals. Neuron. 2017;93:867&#x2013;881. doi: 10.1016/j.neuron.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.01.010</ArticleId><ArticleId IdType="pmc">PMC5325711</ArticleId><ArticleId IdType="pubmed">28162809</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro V., Devine M.J., Higgs N.F., Kittler J.T. Miro1-dependent mitochondrial positioning drives the rescaling of presynaptic Ca2+ signals during homeostatic plasticity. EMBO Rep. 2017;18:231&#x2013;240. doi: 10.15252/embr.201642710.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201642710</ArticleId><ArticleId IdType="pmc">PMC5286383</ArticleId><ArticleId IdType="pubmed">28039205</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyman L., Karbowski M., Lederer W.J. Regulation of Mitochondrial ATP Production: Ca2+ Signaling and Quality Control. Trends Mol. Med. 2020;26:21&#x2013;39. doi: 10.1016/j.molmed.2019.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2019.10.007</ArticleId><ArticleId IdType="pmc">PMC7921598</ArticleId><ArticleId IdType="pubmed">31767352</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpich M., Amini E., Mohamed Z., Ali R.A., Ibrahim N.M., Ahmadiani A. Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neurosci. Ther. 2017;23:5&#x2013;22. doi: 10.1111/cns.12655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12655</ArticleId><ArticleId IdType="pmc">PMC6492703</ArticleId><ArticleId IdType="pubmed">27873462</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moura M.B., dos Santos L.S., Van Houten B. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen. 2010;51:391&#x2013;405. doi: 10.1002/em.20575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/em.20575</ArticleId><ArticleId IdType="pubmed">20544881</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;22:1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1999;26:463&#x2013;471. doi: 10.1016/S0891-5849(98)00216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(98)00216-0</ArticleId><ArticleId IdType="pubmed">9895239</ArticleId></ArticleIdList></Reference><Reference><Citation>Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 1998;28:1309&#x2013;1312. doi: 10.1126/science.281.5381.1309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5381.1309</ArticleId><ArticleId IdType="pubmed">9721092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P.A., Velde C.V., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;8:5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;8:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Fiorenzo P., Nencini M., Cozzolino M., Pesaresi M.G., Valle C., Sepe S., Moreno S., Carr&#xec; M.T. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum. Mol. Genet. 2010;19:4529&#x2013;4542. doi: 10.1093/hmg/ddq383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq383</ArticleId><ArticleId IdType="pmc">PMC3298854</ArticleId><ArticleId IdType="pubmed">20829229</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.Y., Lopez-Gonzalez R., Krishnan G., Phillips H.L., Li A.N., Seeley W.W., Yao W.-D., Almeida S., Gao F.-B. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Jiang J., Garcia S.D., Taylor A.E., Schulte D., Ohkubo T., Schloffman C.L., Maldonado M., Baughn M., et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N., Bieniek K., Zhang Y.-J., Ross K., Gendron T.F., Murray M., Rademakers R., Petrucelli L., Dickson D.W. Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol. Commun. 2018;20:63. doi: 10.1186/s40478-018-0564-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0564-7</ArticleId><ArticleId IdType="pmc">PMC6054740</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Liu H., Itoh K., Oh S., Zhao L., Murata D., Sesaki H., Hartung T., Na C.H., Wang J. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021;33:531&#x2013;546. doi: 10.1016/j.cmet.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8579819</ArticleId><ArticleId IdType="pubmed">33545050</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrador E., Salvador-Palmer R., L&#xf3;pez-Blanch R., Jihad-Jebbar A., Vall&#xe9;s S.L., Estrela J.M. The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS. Int. J. Mol. Sci. 2021;14:6352. doi: 10.3390/ijms22126352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126352</ArticleId><ArticleId IdType="pmc">PMC8231819</ArticleId><ArticleId IdType="pubmed">34198557</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.-F., Gendron T.F., Zhang Y.-J., Lin W.-L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Yan T., Perry G., Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell Neurosci. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L.F. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA. 2014;111:E4439&#x2013;E4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M., Sliter D.A., Kane L.A., Sarraf S.A., Wang C., Burman J.L., Sideris D.P., Fogel A.I., Youle R.J. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309&#x2013;314. doi: 10.1038/nature14893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14893</ArticleId><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.S., Holzbaur E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 2019;122:35&#x2013;40. doi: 10.1016/j.nbd.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.005</ArticleId><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A., Butler K., Long J., Cavey J., Scott D., Shaw B., Sollenberger J., Gell C., Johansen T., Oldham N., et al. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy. 2016;12:1094&#x2013;1104. doi: 10.1080/15548627.2016.1170257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1170257</ArticleId><ArticleId IdType="pmc">PMC4990988</ArticleId><ArticleId IdType="pubmed">27158844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozaki M., Otomo A., Mitsui S., Ono S., Shirakawa R., Chen Y., Hama Y., Sato K., Chen X., Suzuki T., et al. SQSTM1L341Vvariant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells. Neurol. Sci. 2020;22:100301. doi: 10.1016/j.ensci.2020.100301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100301</ArticleId><ArticleId IdType="pmc">PMC7723791</ArticleId><ArticleId IdType="pubmed">33319079</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak J., Szczepanowska J. Zaburzenia dynamiki i dystrybucji mitochondri&#xf3;w w kom&#xf3;rkach w stwardnieniu zanikowym bocznym (ALS) [Dysfunction of mitochondrial dynamic and distribution in Amyotrophic Lateral Sclerosis] Postepy Biochem. 2015;61:183&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">26689011</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller F. The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging. J. Am. Aging Assoc. 2000;23:227&#x2013;253. doi: 10.1007/s11357-000-0022-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-000-0022-9</ArticleId><ArticleId IdType="pmc">PMC3455268</ArticleId><ArticleId IdType="pubmed">23604868</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera-Juli&#xe1; S., Moreno M.L., Barrios C., de la Rubia-Ort&#xed; J.E., Drehmer E. Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Front. Physiol. 2020;6:11&#x2013;63. doi: 10.3389/fphys.2020.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00063</ArticleId><ArticleId IdType="pmc">PMC7016185</ArticleId><ArticleId IdType="pubmed">32116773</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Yamashita T., Tian F., Morimoto N., Ikeda Y., Deguchi K., Abe K. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr. Neurovascular Res. 2013;10:222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Squadrito F., Altavilla D., Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N., Ryu J.J., Choi E.H., Kaushik N.K. Generation and Role of Reactive Oxygen and Nitrogen Species Induced by Plasma, Lasers, Chemical Agents, and Other Systems in Dentistry. Oxid. Med. Cell. Longev. 2017;2017:13. doi: 10.1155/2017/7542540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7542540</ArticleId><ArticleId IdType="pmc">PMC5674515</ArticleId><ArticleId IdType="pubmed">29204250</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010;45:466&#x2013;472. doi: 10.1016/j.exger.2010.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2010.01.003</ArticleId><ArticleId IdType="pmc">PMC2879443</ArticleId><ArticleId IdType="pubmed">20064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Kami K., Fujita Y., Igarashi S., Koike S., Sugawara S., Ikeda S., Sato N., Ito M., Tanaka M., Tomita M., et al. Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations. Mitochondrion. 2012;12:644&#x2013;653. doi: 10.1016/j.mito.2012.07.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2012.07.113</ArticleId><ArticleId IdType="pubmed">22884939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii Y., Yoneda M., Ikawa M., Furukawa T., Kiyono Y., Mori T., Yoshii H., Oyama N., Okazawa H., Saga T., et al. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: Studies with mitochondrial DNA-less &#x3c1;0 cells and cybrids carrying MELAS mitochondrial DNA mutation. Nucl. Med. Biol. 2012;39:177&#x2013;185. doi: 10.1016/j.nucmedbio.2011.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2011.08.008</ArticleId><ArticleId IdType="pubmed">22033022</ArticleId></ArticleIdList></Reference><Reference><Citation>Indo H.P., Davidson M., Yen H.-C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T., Majima H.J. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion. 2007;7:106&#x2013;118. doi: 10.1016/j.mito.2006.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2006.11.026</ArticleId><ArticleId IdType="pubmed">17307400</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1&#x2013;13. doi: 10.1042/BJ20081386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20081386</ArticleId><ArticleId IdType="pmc">PMC2605959</ArticleId><ArticleId IdType="pubmed">19061483</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44&#x2013;84. doi: 10.1016/j.biocel.2006.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2006.07.001</ArticleId><ArticleId IdType="pubmed">16978905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 2015;4:180&#x2013;183. doi: 10.1016/j.redox.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.01.002</ArticleId><ArticleId IdType="pmc">PMC4309861</ArticleId><ArticleId IdType="pubmed">25588755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasuri K., Zhang L., Keller J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 2013;62:170&#x2013;185. doi: 10.1016/j.freeradbiomed.2012.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.09.016</ArticleId><ArticleId IdType="pubmed">23000246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rego A.C., Oliveira C.R. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 2003;28:1563&#x2013;1574. doi: 10.1023/A:1025682611389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025682611389</ArticleId><ArticleId IdType="pubmed">14570402</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.-J., Wang X., Wang T.-Y., Lin Z.-Z., Hu Y.-J., Huang Z.-L., Yang X.-J., Xu P. Flavonoids from Rosa roxburghii Tratt prevent reactive oxygen species-mediated DNA damage in thymus cells both combined with and without PARP-1 expression after exposure to radiation in vivo. Aging. 2020;12:16368&#x2013;16389. doi: 10.18632/aging.103688.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103688</ArticleId><ArticleId IdType="pmc">PMC7485694</ArticleId><ArticleId IdType="pubmed">32862153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S., Abramov A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell Longev. 2012;2012:11. doi: 10.1155/2012/428010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/428010</ArticleId><ArticleId IdType="pmc">PMC3362933</ArticleId><ArticleId IdType="pubmed">22685618</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten D.A., Germain M., Kelly M.A., Slack R.S. Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration. J. Alzheimers Dis. 2010;20((Suppl. S2)):S357&#x2013;S367. doi: 10.3233/JAD-2010-100498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-100498</ArticleId><ArticleId IdType="pubmed">20421690</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro R.M. Reactive oxygen species at phospholipid bilayers: Distribution, mobility and permeation. Biochim. Biophys. Acta. 2014;1838:438&#x2013;444. doi: 10.1016/j.bbamem.2013.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2013.09.016</ArticleId><ArticleId IdType="pubmed">24095673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunomura A., Honda K., Takeda A., Hirai K., Zhu X., Smith M.A., Perry G. Oxidative damage to RNA in neurodegenerative diseases. J. Biomed. Biotechnol. 2006;2006:082323 . doi: 10.1155/JBB/2006/82323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/JBB/2006/82323</ArticleId><ArticleId IdType="pmc">PMC1559934</ArticleId><ArticleId IdType="pubmed">17047315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobley J.N., Fiorello M.L., Bailey D.M. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018;15:490&#x2013;503. doi: 10.1016/j.redox.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.01.008</ArticleId><ArticleId IdType="pmc">PMC5881419</ArticleId><ArticleId IdType="pubmed">29413961</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpkins J.W., Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res. Rev. 2008;57:421&#x2013;430. doi: 10.1016/j.brainresrev.2007.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2007.04.007</ArticleId><ArticleId IdType="pubmed">17512984</ArticleId></ArticleIdList></Reference><Reference><Citation>Formella I., Svahn A., Radford R.A., Don E., Cole N., Hogan A., Lee A., Chung R.S., Morsch M. Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons in vivo. Redox Biol. 2018;19:226&#x2013;234. doi: 10.1016/j.redox.2018.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.08.011</ArticleId><ArticleId IdType="pmc">PMC6126400</ArticleId><ArticleId IdType="pubmed">30193184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Xu E., Musich P.R., Lin F. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci. Ther. 2019;25:816&#x2013;824. doi: 10.1111/cns.13116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13116</ArticleId><ArticleId IdType="pmc">PMC6566063</ArticleId><ArticleId IdType="pubmed">30889315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Riluzole and ALS therapy. Wien. Med. Wochenschr. 1996;146:185&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">8873431</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh K.M., Hwang J.Y., Shin H.C., Koh J.Y. A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C. Neurobiol. Dis. 2000;7:375&#x2013;383. doi: 10.1006/nbdi.2000.0297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0297</ArticleId><ArticleId IdType="pubmed">10964608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala G., Arosio A., Conti E., Beretta S., Lunetta C., Riva N., Ferrarese C., Tremolizzo L. Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes. Clin. Psychopharmacol. Neurosci. 2019;31:438&#x2013;442. doi: 10.9758/cpn.2019.17.3.438.</Citation><ArticleIdList><ArticleId IdType="doi">10.9758/cpn.2019.17.3.438</ArticleId><ArticleId IdType="pmc">PMC6705104</ArticleId><ArticleId IdType="pubmed">31352711</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C., Ma W., Zheng W., Huang H., Xia R., Li C., Zhu X. The antioxidant effects of riluzole on the APRE-19 celll model injury-induced by t-BHP. BMC Ophthalmol. 2017;23:210. doi: 10.1186/s12886-017-0614-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-017-0614-0</ArticleId><ArticleId IdType="pmc">PMC5701292</ArticleId><ArticleId IdType="pubmed">29169345</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Al Khleifat A., Meurgey J.H., Jones A., Leigh P.N., Bensimon G., Al-Chalabi A. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: A retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416&#x2013;422. doi: 10.1016/S1474-4422(18)30054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst Rev. 2012;2012:CD001447. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack J.G., Denton R.M. The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase complex. Biochem. J. 1979;180:533&#x2013;544. doi: 10.1042/bj1800533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj1800533</ArticleId><ArticleId IdType="pmc">PMC1161091</ArticleId><ArticleId IdType="pubmed">39549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouaville L.S., Pinton P., Bastianutto C., Rutter G.A., Rizzuto R. Regulation of mitochondrial ATP synthesis by calcium: Evidence for a long-term metabolic priming. Proc. Natl. Acad. Sci. USA. 1999;96:13807&#x2013;13812. doi: 10.1073/pnas.96.24.13807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.24.13807</ArticleId><ArticleId IdType="pmc">PMC24146</ArticleId><ArticleId IdType="pubmed">10570154</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal M.K. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li A., Li X., Yi J. Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model. Arch. Biochem. Biophys. 2019;663:249&#x2013;258. doi: 10.1016/j.abb.2019.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2019.01.024</ArticleId><ArticleId IdType="pmc">PMC6506190</ArticleId><ArticleId IdType="pubmed">30682329</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.R., Yang E.J. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations. Diagnostics. 2021;26:1546. doi: 10.3390/diagnostics11091546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091546</ArticleId><ArticleId IdType="pmc">PMC8465946</ArticleId><ArticleId IdType="pubmed">34573888</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaganjac M., Milkovic L., Sunjic S.B., Zarkovic N. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants. 2020;19:1151. doi: 10.3390/antiox9111151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9111151</ArticleId><ArticleId IdType="pmc">PMC7699519</ArticleId><ArticleId IdType="pubmed">33228209</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashi R., Patel B.M. NRF2 in Cardiovascular Diseases: A Ray of Hope! J. Cardiovasc. Transl. Res. 2021;14:573&#x2013;586. doi: 10.1007/s12265-020-10083-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-020-10083-8</ArticleId><ArticleId IdType="pubmed">33241490</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H., Tundis R., Ullah H.U., Aschner M., Belwal T., Mirzaei H., Akkol E.K. Flavonoids targeting NRF2 in neurodegenerative disorders. Food Chem. Toxicol. 2020;146:111817. doi: 10.1016/j.fct.2020.111817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2020.111817</ArticleId><ArticleId IdType="pubmed">33069760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarlette A., Krampfl K., Grothe C., Neuhoff N., Dengler R., Petri S. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2008;67:1055&#x2013;1062. doi: 10.1097/NEN.0b013e31818b4906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818b4906</ArticleId><ArticleId IdType="pubmed">18957896</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo G.M., Manfredi G. Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control. Brain Res. 2015;1607:36&#x2013;46. doi: 10.1016/j.brainres.2014.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.065</ArticleId><ArticleId IdType="pmc">PMC4385426</ArticleId><ArticleId IdType="pubmed">25301687</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Talbot K. The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS. Front. Cell. Neurosci. 2021;15:653688. doi: 10.3389/fncel.2021.653688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.653688</ArticleId><ArticleId IdType="pmc">PMC8047135</ArticleId><ArticleId IdType="pubmed">33867942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Y., Hu J., Che Y., Liu Y., Luo Z., Cheng J., Han Q., He H., Zhou Q. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response. Cell Death Dis. 2022;13:156. doi: 10.1038/s41419-022-04602-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04602-5</ArticleId><ArticleId IdType="pmc">PMC8850591</ArticleId><ArticleId IdType="pubmed">35173147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gala M.G., V&#xf6;gtle F. Mitochondrial proteases in human diseases. FEBS Lett. 2021;595:1205&#x2013;1222. doi: 10.1002/1873-3468.14039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14039</ArticleId><ArticleId IdType="pubmed">33453058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.M., Liu N., Qin Z.H., Wang Y. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol. Sin. 2022;10:1038. doi: 10.1038/s41401-022-00879-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00879-6</ArticleId><ArticleId IdType="pubmed">35233090</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Horssen J., van Schaik P., Witte M. Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? Neurosci. Lett. 2019;710:132931. doi: 10.1016/j.neulet.2017.06.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.050</ArticleId><ArticleId IdType="pubmed">28668382</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna-S&#xe1;nchez M., Bianchi P., Quintana A. Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within. Int. J. Mol. Sci. 2021;22:8523. doi: 10.3390/ijms22168523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168523</ArticleId><ArticleId IdType="pmc">PMC8395232</ArticleId><ArticleId IdType="pubmed">34445229</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Zhang Y., Wen D., Duan W., An T., Shi P., Wang J., Li Z., Chen X., Li C. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab. Investig. 2013;93:825&#x2013;833. doi: 10.1038/labinvest.2013.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.73</ArticleId><ArticleId IdType="pubmed">23711824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed T., Zulfiqar A., Arguelles S., Rasekhian M., Nabavi S.F., Silva A.S., Nabavi S.M. Map kinase signaling as therapeutic target for neurodegeneration. Pharmacol. Res. 2020;160:105090. doi: 10.1016/j.phrs.2020.105090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105090</ArticleId><ArticleId IdType="pubmed">32707231</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094&#x2013;4125. doi: 10.1007/s12035-015-9337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9337-5</ArticleId><ArticleId IdType="pmc">PMC4937091</ArticleId><ArticleId IdType="pubmed">26198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgi C., Marchi S., Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 2018;19:713&#x2013;730. doi: 10.1038/s41580-018-0052-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0052-8</ArticleId><ArticleId IdType="pubmed">30143745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Engelhardt J., Harati Y., Smith R.G., Jo&#xf3; F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., Ferri A., Battistoni A., Famhy L., Gabbianelli R., Poccia F., Rotilio G. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 1997;414:365&#x2013;368. doi: 10.1016/s0014-5793(97)01051-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(97)01051-x</ArticleId><ArticleId IdType="pubmed">9315720</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.-F., Vizcay-Barrena G., Lin W.-L., Xu Y.-F., Lewis J., et al. ER&#x2013;mitochondria associations are regulated by the VAPB&#x2013;PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., Paillusson S., Gomez-Suaga P., Mitchell J.C., Lau D.H.W., Gray E.H., Sancho R.M., Vizcay-Barrena G., De Vos K.J., Shaw C.E., et al. ALS/FTD-associated FUS activates GSK-3&#x3b2; to disrupt the VAPB&#x2014;PTPIP 51 interaction and ER&#x2014;mitochondria associations. EMBO Rep. 2016;17:1326&#x2013;1342. doi: 10.15252/embr.201541726.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541726</ArticleId><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>Guatteo E., Carunchio I., Pieri M., Albo F., Canu N., Mercuri N.B., Zona C. Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels&#x2019; activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:90&#x2013;100. doi: 10.1016/j.nbd.2007.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.002</ArticleId><ArticleId IdType="pubmed">17706428</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., M&#xf3;rotz G.M., Stoica R., Tudor E.L., Lau K.-F., Ackerley S., Warley A., Shaw C.E., Miller C.C.J. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 2012;21:1299&#x2013;1311. doi: 10.1093/hmg/ddr559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr559</ArticleId><ArticleId IdType="pmc">PMC3284118</ArticleId><ArticleId IdType="pubmed">22131369</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf3;rotz G.M., De Vos K.J., Vagnoni A., Ackerley S., Shaw C.E., Miller C.C. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 2012;21:1979&#x2013;1988. doi: 10.1093/hmg/dds011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds011</ArticleId><ArticleId IdType="pmc">PMC3315205</ArticleId><ArticleId IdType="pubmed">22258555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Anagnostou G., Akbar M.T., Paul P., Angelinetta C., Steiner T.J., de Belleroche J. Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging. 2010;31:969&#x2013;985. doi: 10.1016/j.neurobiolaging.2008.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.07.005</ArticleId><ArticleId IdType="pubmed">18701194</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Farrimond L., Candalija A., Scaber J., Ababneh N.A., Sathyaprakash C., Vowles J., Cowley S.A., Talbot K. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Stem Cell Rep. 2020;14:892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F., Kalmbach N., Naujock M., Staege S., Eggenschwiler R., Abo-Rady M., Japtok J., Guo W., Hensel N., Reinhardt P., et al. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum. Mol. Genet. 2019;28:2835&#x2013;2850. doi: 10.1093/hmg/ddz107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz107</ArticleId><ArticleId IdType="pubmed">31108504</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehvil&#xe4;inen P., Koistinaho J., Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:126. doi: 10.3389/fncel.2014.00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00126</ArticleId><ArticleId IdType="pmc">PMC4023018</ArticleId><ArticleId IdType="pubmed">24847211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntley M.L., Gao J., Termsarasab P., Wang L., Zeng S., Thammongkolchai T., Liu Y., Cohen M.L., Wang X. Association between TDP-43 and mitochondria in inclusion body myositis. Lab. Investig. 2019;99:1041&#x2013;1048. doi: 10.1038/s41374-019-0233-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0233-x</ArticleId><ArticleId IdType="pmc">PMC6609472</ArticleId><ArticleId IdType="pubmed">30742062</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy Y.A., Deng W., Stoddart J., Chung R., Guillemin G., Cole N., Neely G.G., Hesselson D. &#x201c;STRESSED OUT&#x201d;: The role of FUS and TDP-43 in amyotrophic lateral sclerosis. Int. J. Biochem. Cell Biol. 2020;126:105821. doi: 10.1016/j.biocel.2020.105821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2020.105821</ArticleId><ArticleId IdType="pubmed">32758633</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N., Iacomino N., Colombo S.F., Navone F. The Link between VAPB Loss of Function and Amyotrophic Lateral Sclerosis. Cells. 2021;10:1865. doi: 10.3390/cells10081865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081865</ArticleId><ArticleId IdType="pmc">PMC8392409</ArticleId><ArticleId IdType="pubmed">34440634</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T.Y., Tsai S.A., Su T.P. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. J. Biomed. Sci. 2017;24:74. doi: 10.1186/s12929-017-0380-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-017-0380-6</ArticleId><ArticleId IdType="pmc">PMC5603014</ArticleId><ArticleId IdType="pubmed">28917260</ArticleId></ArticleIdList></Reference><Reference><Citation>Zgorzynska E., Dziedzic B., Walczewska A. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:9592. doi: 10.3390/ijms22179592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179592</ArticleId><ArticleId IdType="pmc">PMC8431732</ArticleId><ArticleId IdType="pubmed">34502501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermosura M.C., Garruto R.M. TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD? Biochim. Biophys. Acta. 2007;1772:822&#x2013;835. doi: 10.1016/j.bbadis.2007.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2007.02.008</ArticleId><ArticleId IdType="pmc">PMC1994999</ArticleId><ArticleId IdType="pubmed">17395433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen D., Cui C., Duan W., Wang W., Wang Y., Liu Y., Li Z., Li C. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector. Brain Res. Bull. 2019;144:1&#x2013;13. doi: 10.1016/j.brainresbull.2018.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.09.015</ArticleId><ArticleId IdType="pubmed">30414993</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona J.C., Duchen M.R. PPAR as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic. Biol. Med. 2016;100:153&#x2013;163. doi: 10.1016/j.freeradbiomed.2016.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.06.023</ArticleId><ArticleId IdType="pmc">PMC5145801</ArticleId><ArticleId IdType="pubmed">27352979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M., Kipiani K., Chen J., Calingasan N.Y., Beal M.F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2005;191:331&#x2013;336. doi: 10.1016/j.expneurol.2004.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2004.10.007</ArticleId><ArticleId IdType="pubmed">15649489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Kawaguchi-Niida M., Yamamoto T., Toi S., Hirano A., Kobayashi M. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis. Neuropathology. 2008;28:387&#x2013;398. doi: 10.1111/j.1440-1789.2008.00890.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2008.00890.x</ArticleId><ArticleId IdType="pubmed">18312546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Li S., Zheng C., Wang F., Luo Y., Wu L., Cao J., Guo B., Yu P., Zhang G., et al. Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1&#x3b1;/Nrf2/HO-1 pathway in ALS mice. Neuropharmacology. 2021;182:108380. doi: 10.1016/j.neuropharm.2020.108380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2020.108380</ArticleId><ArticleId IdType="pubmed">33152451</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A., Menzl J., Podolsky T.C., Manzo E., Estes P.S., Ashford S., Zarnescu D.C. PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43. Hum. Mol. Genet. 2015;24:1741&#x2013;1754. doi: 10.1093/hmg/ddu587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu587</ArticleId><ArticleId IdType="pmc">PMC4381760</ArticleId><ArticleId IdType="pubmed">25432537</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Mart&#xed;nez-Palma L., Souza J.M., Bolatto C., Rodr&#xed;guez-Bottero S., Logan A., Smith R.A., Murphy M.P., Barbeito L., et al. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2014;70:204&#x2013;213. doi: 10.1016/j.freeradbiomed.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Fancelli D., Wong M., Niedzwiecki M., Ballarini M., Plyte S., Chang Q. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:433. doi: 10.3389/fncel.2014.00433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00433</ArticleId><ArticleId IdType="pmc">PMC4271619</ArticleId><ArticleId IdType="pubmed">25565966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordet T., Buisson B., Michaud M., Drouot C., Gal&#xe9;a P., Delaage P., Akentieva N.P., Evers A., Covey D.F., Ostuni M., et al. Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis. J. Pharmacol. Exp. Ther. 2007;322:709&#x2013;720. doi: 10.1124/jpet.107.123000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.107.123000</ArticleId><ArticleId IdType="pubmed">17496168</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunyach C., Michaud M., Arnoux T., Bernard-Marissal N., Aebischer J., Latyszenok V., Gouarne C., Raoul C., Pruss R.M., Bordet T., et al. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model. Neuropharmacology. 2012;62:2346&#x2013;2352. doi: 10.1016/j.neuropharm.2012.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.02.013</ArticleId><ArticleId IdType="pubmed">22369784</ArticleId></ArticleIdList></Reference><Reference><Citation>Medhi B., Batra G., Jain M., Singh R.S., Sharma A.R., Singh A., Prakash A. Novel therapeutic targets for amyotrophic lateral sclerosis. Indian J. Pharmacol. 2019;51:418&#x2013;425. doi: 10.4103/ijp.IJP_823_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijp.IJP_823_19</ArticleId><ArticleId IdType="pmc">PMC6984016</ArticleId><ArticleId IdType="pubmed">32029967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono Y., Tanaka H., Takata M., Nagahara Y., Noda Y., Tsuruma K., Shimazawa M., Hozumi I., Hara H. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci. Lett. 2014;559:174&#x2013;178. doi: 10.1016/j.neulet.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.12.005</ArticleId><ArticleId IdType="pubmed">24334165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda T., Ito T., Inden M., Kurita H., Yamamoto A., Hozumi I. Stem Cells from Human Exfoliated Deciduous Teeth-Conditioned Medium (SHED-CM) is a Promising Treatment for Amyotrophic Lateral Sclerosis. Front. Pharmacol. 2022;13:805379. doi: 10.3389/fphar.2022.805379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.805379</ArticleId><ArticleId IdType="pmc">PMC8850386</ArticleId><ArticleId IdType="pubmed">35185565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Jo M., Lee H.E., Jeon Y.-M., Kim S., Kwon Y., Woo J., Han S., Mun J.Y., Kim H.-J. HEXA-018, a Novel Inducer of Autophagy, Rescues TDP-43 Toxicity in Neuronal Cells. Front. Pharmacol. 2021;12:747975. doi: 10.3389/fphar.2021.747975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.747975</ArticleId><ArticleId IdType="pmc">PMC8675103</ArticleId><ArticleId IdType="pubmed">34925009</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Savelieff M., Sakowski S.A., Feldman E.L. Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials. Expert Opin. Investig. Drugs. 2019;28:525&#x2013;543. doi: 10.1080/13543784.2019.1627324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2019.1627324</ArticleId><ArticleId IdType="pmc">PMC6697143</ArticleId><ArticleId IdType="pubmed">31189354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam A., Loo S., Dutta B., Sze S.K., Tam J.P. Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics. J. Biol. Chem. 2019;294:4000&#x2013;4011. doi: 10.1074/jbc.RA118.006693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006693</ArticleId><ArticleId IdType="pmc">PMC6422099</ArticleId><ArticleId IdType="pubmed">30674551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottani E., Lamperti C., Prigione A., Tiranti V., Persico N., Brunetti D. Therapeutic Approaches to Treat Mitochondrial Diseases: &#x201c;One-Size-Fits-All&#x201d; and &#x201c;Precision Medicine&#x201d; Strategies. Pharmaceutics. 2020;12:1083. doi: 10.3390/pharmaceutics12111083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics12111083</ArticleId><ArticleId IdType="pmc">PMC7696526</ArticleId><ArticleId IdType="pubmed">33187380</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Du W., Zhao Y., Lim K., Lu L., Zhang C., Li L. Mitochondria targeting drugs for neurodegenerative diseases&#x2014;Design, mechanism and application. Acta Pharm. Sin. B. 2022;12:2778&#x2013;2789. doi: 10.1016/j.apsb.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2022.03.001</ArticleId><ArticleId IdType="pmc">PMC9214044</ArticleId><ArticleId IdType="pubmed">35755284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Ferri A., Carri M.T. Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications. Antioxidants Redox Signal. 2008;10:405&#x2013;444. doi: 10.1089/ars.2007.1760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1760</ArticleId><ArticleId IdType="pubmed">18370853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Liu J., Guan Y., Zhao Z., Meng F., Wang X., Gao X., Zhou F., Chen Y., Wang X. The mechanism of the WNT5A and FZD4 receptor mediated WNT/&#x3b2;-catenin pathway in the degeneration of ALS spinal cord motor neurons. Biochem. Biophys. Res. Commun. 2022;609:23&#x2013;30. doi: 10.1016/j.bbrc.2022.03.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.03.126</ArticleId><ArticleId IdType="pubmed">35413536</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhou F., Guan Y., Meng F., Zhao Z., Su Q., Bao W., Wang X., Zhao J., Huo Z., et al. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells. 2022;11:572. doi: 10.3390/cells11030572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030572</ArticleId><ArticleId IdType="pmc">PMC8833997</ArticleId><ArticleId IdType="pubmed">35159383</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J.S., Genge A., Chio A., Estol C.J., Chaverri D., Hern&#xe1;ndez M., Mar&#xed;n S., Mascias J., Rodriguez G.E., Povedano M., et al. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomized clinical trial. Amyotroph. Lateral Scler. Front. Degener. 2020;21:5&#x2013;14. doi: 10.1080/21678421.2019.1632346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>